GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: ADMS
Neutral $26

Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) rated to Neutral with price target $26 by Mizuho

Tuesday,  Jan 19, 2016  8:25 AM ET by Lynn Gilbert

Mizuho rated Adamas Pharmaceuticals
Inc. (NASDAQ: ADMS) to Neutral with price target $26.



Mizuho



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy